{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00088",
      "entity_text" : "ICS",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF00067",
      "entity_text" : "cytochrome P450",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The inhibitors of cytochrome P450, when co-administered, can increase the bio-availability of ICS / INS, leading to increased level of steroids in the systemic circulation, resulting in increased risk of systemic adverse effects.",
  "reading_complete" : "2020-08-03T09:34:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:29:07Z",
  "trigger" : "increase",
  "evidence" : [ "cytochrome P450, when co-administered, can increase the bio-availability of ICS" ],
  "pmc_id" : "4319196",
  "score" : 0
}